The July JASE contains, “Superior Prognostic Value of Right Ventricular Free Wall Compared to Global Longitudinal Strain in Patients with Heart Failure,” by Carluccio et al. Dr. Carluccio said, “Results of this study provide substantial new insights in right ventricular (RV) function assessment and risk stratification of heart failure (HF) patients with reduced ejection fraction (HFrEF), with important clinical implication. This study, for the first time, clearly shows that, at least in HFrEF patients, the independent contribution of RVGLS to the prediction of outcome is lost when parameters of LV systolic function are taken into account, suggesting that prognostic performance of RVGLS might be hampered by concomitant impairment in global LV systolic function involving the interventricular septum. In contrast, the prognostic role of RVFWS is not affected by LV systolic dysfunction.”
Other JASE articles cover echocardiography in pulmonary embolism, echocardiographic assessment of patent foramen ovale, coronary microvascular dysfunction, assessing treatment of obstructive sleep apnea by echocardiography, longitudinal strain, measuring with echocardiography, and echocardiography in infants and children along with several brief communications and an editorial comment by Drs. Lopez and Colan, “How Well Does the Neonatal Heart Measure Up?” Read the first President’s Message by Madhav Swaminathan, MD, MMCi, FASE, “Creating a Caring Society,” and the Sonographers’ Communication by Raymond Musarra, BSAS, RCS, RDCS, FASE, “Changing Healthcare Costs Impact the Way We Provide Patient Care.”
We are pleased to announce that the 2018 Impact Factor for JASE is 6.111 keeping JASE in its competitive place among cardiology journals with a ranking of 17 out of 136 publications.